Part 5: Acute Coronary Syndromes 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations
暂无分享,去创建一个
R. O’Connor | L. Bossaert | F. Beygui | H. Nonogi | D. Walters | M. Welsford | N. Nikolaou | C. Ghaemmaghami | K. Woolfrey | T. Scott | D. Pichel | Co-Chair | Robert E. O’Connor | Darren L. Walters | Co-Chair
[1] H. Arntz,et al. [Role of coronary intervention after successful cardiopulmonary resuscitation]. , 2016, Herzschrittmachertherapie & Elektrophysiologie.
[2] Peter Cameron,et al. Air Versus Oxygen in ST-Segment–Elevation Myocardial Infarction , 2015, Circulation.
[3] A. Kirtane,et al. Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors , 2014, BMJ : British Medical Journal.
[4] A. Kelly,et al. Prospective external validation of an accelerated (2-h) acute coronary syndrome rule-out process using a contemporary troponin assay , 2014, International Journal of Emergency Medicine.
[5] P. Armstrong,et al. ST–Segment-Elevation Myocardial Infarction Patients Randomized to a Pharmaco-Invasive Strategy or Primary Percutaneous Coronary Intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-Year Mortality Follow-Up , 2014, Circulation.
[6] E. Vicaut,et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. , 2014, The New England journal of medicine.
[7] M. Sabatine,et al. Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials , 2014, The Lancet.
[8] H. Snooks,et al. Effects of prehospital 12-lead ECG on processes of care and mortality in acute coronary syndrome: a linked cohort study from the Myocardial Ischaemia National Audit Project , 2014, Heart.
[9] Eugenia Yu,et al. Development and validation of a prediction rule for early discharge of low-risk emergency department patients with potential ischemic chest pain. , 2014, CJEM.
[10] J. Boivin,et al. Computerized interpretation of the prehospital electrocardiogram: predictive value for ST segment elevation myocardial infarction and impact on on-scene time. , 2014, CJEM.
[11] J. Greenslade,et al. The new Vancouver Chest Pain Rule using troponin as the only biomarker: an external validation study. , 2014, The American journal of emergency medicine.
[12] J. Greenslade,et al. Validation of an accelerated high‐sensitivity troponin T assay protocol in an Australian cohort with chest pain , 2014, The Medical journal of Australia.
[13] J. Tamayo-Sarver,et al. Effect of Prehospital Cardiac Catheterization Lab Activation on Door-to-Balloon Time, Mortality, and False-Positive Activation , 2014, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.
[14] Barbara T. Unger,et al. Early cardiac catheterization is associated with improved survival in comatose survivors of cardiac arrest without STEMI. , 2014, Resuscitation.
[15] S. Pocock,et al. Bivalirudin started during emergency transport for primary PCI. , 2013, The New England journal of medicine.
[16] I. Porto,et al. Comparison of pre-hospital 600 mg or 900 mg vs. peri-interventional 300 mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load&Go randomized trial. , 2013, International journal of cardiology.
[17] C. Reid,et al. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. , 2013, Journal of the American College of Cardiology.
[18] A. Singer,et al. Identifying patients for early discharge: performance of decision rules among patients with acute chest pain. , 2013, International journal of cardiology.
[19] Fiona Stewart,et al. The Cochrane collaboration's tool for assessing risk of bias , 2013 .
[20] Kurt S. Hoffmayer,et al. Comparison of clinical characteristics and outcomes of cardiac arrest survivors having versus not having coronary angiography. , 2013, The American journal of cardiology.
[21] P. Armstrong,et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.
[22] L. Morrison,et al. Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study. , 2013, American heart journal.
[23] P. Pek,et al. Nationwide improvement of door-to-balloon times in patients with acute ST-segment elevation myocardial infarction requiring primary percutaneous coronary intervention with out-of-hospital 12-lead ECG recording and transmission. , 2013, Annals of emergency medicine.
[24] S. Wilber,et al. Prehospital Electrocardiographic Computer Identification of ST-segment Elevation Myocardial Infarction , 2013, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.
[25] Jane A. Linderbaum,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[26] Deepak L. Bhatt,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.
[27] G. Trillò,et al. Impact of emergency coronary angiography on in-hospital outcome of unconscious survivors after out-of-hospital cardiac arrest. , 2012, The American journal of cardiology.
[28] Ke Xu,et al. Impact of the prehospital activation strategy in patients with ST-elevation myocardial infarction undergoing primary percutaneous revascularization: a single center community hospital experience. , 2012, Critical pathways in cardiology.
[29] A. Chan,et al. Improved survival associated with pre-hospital triage strategy in a large regional ST-segment elevation myocardial infarction program. , 2012, JACC. Cardiovascular interventions.
[30] L. Køber,et al. Emergency coronary angiography in comatose cardiac arrest patients: do real-life experiences support the guidelines? , 2012, European heart journal. Acute cardiovascular care.
[31] Fred S Apple,et al. Third universal definition of myocardial infarction , 2012 .
[32] D. Atar,et al. ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .
[33] C. Schmidt,et al. To transmit or not to transmit: how good are emergency medical personnel in detecting STEMI in patients with chest pain? , 2012, The Canadian journal of cardiology.
[34] V. Nanjayya,et al. Immediate coronary angiogram in comatose survivors of out-of-hospital cardiac arrest--an Australian study. , 2012, Resuscitation.
[35] M. Copass,et al. Comparison of role of early (less than six hours) to later (more than six hours) or no cardiac catheterization after resuscitation from out-of-hospital cardiac arrest. , 2012, The American journal of cardiology.
[36] R. Argyle,et al. High-concentration versus titrated oxygen therapy in ST-elevation myocardial infarction: a pilot randomized controlled trial. , 2012, American heart journal.
[37] Robert J Brison,et al. Development of a clinical prediction rule for 30-day cardiac events in emergency department patients with chest pain and possible acute coronary syndrome. , 2012, Annals of emergency medicine.
[38] F. McAlister,et al. Antiarrhythmic Therapies for the Prevention of Sudden Cardiac Death , 1997, Drugs.
[39] H. Mayr,et al. Prehospital treatment of patients with acute myocardial infarction with bivalirudin. , 2012, The American journal of emergency medicine.
[40] Maarten L. Simoons,et al. The third universal definition of myocardial infarction , 2013 .
[41] K. Huber,et al. Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial , 2012, Clinical Research in Cardiology.
[42] T. Henry,et al. Benefit of Transferring ST-Segment–Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase , 2011, Circulation.
[43] Roger D. White,et al. Impact of Prehospital Electrocardiogram Protocol and Immediate Catheterization Team Activation for Patients With ST-Elevation–Myocardial Infarction , 2011, Circulation. Cardiovascular quality and outcomes.
[44] Susan Mallett,et al. QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies , 2011, Annals of Internal Medicine.
[45] K. Sunde,et al. Strong and weak aspects of an established post-resuscitation treatment protocol-A five-year observational study. , 2011, Resuscitation.
[46] E. Vicaut,et al. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial , 2011, The Lancet.
[47] A. Richards,et al. Early dynamic change in high-sensitivity cardiac troponin T in the investigation of acute myocardial infarction. , 2011, Clinical chemistry.
[48] Barbara T. Unger,et al. Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest: Evaluation of a Regional System to Increase Access to Cooling , 2011, Circulation.
[49] Rolf Lefering,et al. ROSC after cardiac arrest--the RACA score to predict outcome after out-of-hospital cardiac arrest. , 2011, European heart journal.
[50] G. Schuler,et al. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment , 2011, JACC. Cardiovascular interventions.
[51] C. Lory,et al. Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation , 2011, Critical care.
[52] X. Combes,et al. Predictive factors for positive coronary angiography in out-of-hospital cardiac arrest patients , 2011, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.
[53] J. Qiu,et al. Direct ambulance transport to catheterization laboratory reduces door-to-balloon time in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the DIRECT-STEMI study. , 2011, Chinese medical journal.
[54] Marco Onofri,et al. Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[55] P. Armstrong,et al. The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: a pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST. , 2011, American heart journal.
[56] Kari Kuulasmaa,et al. World Health Organization definition of myocardial infarction: 2008-09 revision. , 2011, International journal of epidemiology.
[57] C. Terkelsen,et al. Urban and rural implementation of pre-hospital diagnosis and direct referral for primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction. , 2011, European heart journal.
[58] H. Thiele,et al. in ST-Segment Myocardial Infarction) LIPSIA-STEMI Trial (Leipzig Immediate Prehospital Facilitated Angioplasty Acute Myocardial Infarction Very Early After Symptom Onset: The in Coronary Intervention Versus Primary Percutaneous Coronary Intervention Randomized Comparison of Pre-HospitalInitiated Fac , 2011 .
[59] G. Wagner,et al. Paramedics as decision makers on the activation of the catheterization laboratory in the presence of acute ST-elevation myocardial infarction. , 2011, Journal of electrocardiology.
[60] P. Macfarlane,et al. Automated electrocardiogram interpretation programs versus cardiologists' triage decision making based on teletransmitted data in patients with suspected acute coronary syndrome. , 2010, The American journal of cardiology.
[61] M. Hazinski,et al. Pediatric Basic and Advanced Life Support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations , 2010, Pediatrics.
[62] J. Nolan,et al. Part 9: Acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. , 2010, Circulation.
[63] J. Nolan,et al. Part 9: Acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. , 2010, Resuscitation.
[64] Takumi Kimura,et al. Comparison of long-term prognostic evaluation between pre-intervention thrombolysis and primary coronary intervention: a prospective randomized trial: five-year results of the IMPORTANT study. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[65] Takumi Kimura,et al. Comparison of Long-Term Prognostic Evaluation Between Pre-Intervention Thrombolysis and Primary Coronary Intervention: A Prospective Randomized Trial , 2010 .
[66] X. Jouven,et al. Immediate Percutaneous Coronary Intervention Is Associated With Better Survival After Out-of-Hospital Cardiac Arrest: Insights From the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) Registry , 2010, Circulation. Cardiovascular interventions.
[67] Carin M. Van Gelder,et al. Early Cardiac Catheterization Laboratory Activation by Paramedics for Patients with ST-segment Elevation Myocardial Infarction on Prehospital 12-Lead Electrocardiograms , 2010, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.
[68] S. Iliceto,et al. Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all. , 2010, European heart journal.
[69] S. Halvorsen,et al. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). , 2010, Journal of the American College of Cardiology.
[70] P. Widimsky. Primary angioplasty vs. thrombolysis: the end of the controversy? , 2009, European heart journal.
[71] L. Morrison,et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. , 2009, The New England journal of medicine.
[72] K. Sunde,et al. Outcome, timing and adverse events in therapeutic hypothermia after out‐of‐hospital cardiac arrest , 2009, Acta anaesthesiologica Scandinavica.
[73] P. Touboul,et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. , 2009, European heart journal.
[74] T. Engstrøm,et al. Feasibility and safety of prehospital administration of bivalirudin in patients with ST-elevation myocardial infarction. , 2009, The American journal of cardiology.
[75] C. Callaway,et al. Review of A Large Clinical Series: Coronary Angiography Predicts Improved Outcome Following Cardiac Arrest: Propensity-adjusted Analysis , 2009, Journal of intensive care medicine.
[76] H. Genzwürker,et al. Reperfusion rate and inhospital mortality of patients with ST segment elevation myocardial infarction diagnosed already in the prehospital phase: results of the German Prehospital Myocardial Infarction Registry (PREMIR). , 2009, Resuscitation.
[77] C. Cannon,et al. Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry. , 2009, Journal of the American College of Cardiology.
[78] D. Cone,et al. Can Paramedics Read ST-segment Elevation Myocardial Infarction on Prehospital 12-Lead Electrocardiograms? , 2009, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.
[79] B. Gersh,et al. Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention with Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Acute Myocardial Infarction: Data From the French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI) , 2009 .
[80] R. Brison,et al. Impact of a rapid access protocol on decreasing door-to-balloon time in acute ST elevation myocardial infarction. , 2009, CJEM.
[81] Denise O'Connor,et al. Chapter 5: Defining the review question and developing criteria for including studies , 2008 .
[82] A. Shah,et al. A comparison of door-to-balloon times and false-positive activations between emergency department and out-of-hospital activation of the coronary catheterization team. , 2008, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[83] J. Ferrières,et al. Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Acute Myocardial Infarction Data From the French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI) , 2008 .
[84] J. Greenwood,et al. Direct ambulance admission to the cardiac catheterization laboratory significantly reduces door-to-balloon times in primary percutaneous coronary intervention. , 2008, American heart journal.
[85] E. Topol,et al. Facilitated PCI in patients with ST-elevation myocardial infarction. , 2008, The New England journal of medicine.
[86] Ori Ben-Yehuda,et al. Effect of prehospital 12-lead electrocardiogram on activation of the cardiac catheterization laboratory and door-to-balloon time in ST-segment elevation acute myocardial infarction. , 2008, The American journal of cardiology.
[87] J. Alpert,et al. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction , 2008 .
[88] W. Kochman,et al. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals. , 2007, European heart journal.
[89] M. Ward,et al. Field triage to primary angioplasty combined with emergency department bypass reduces treatment delays and is associated with improved outcome. , 2007, European heart journal.
[90] Edo Kaluski,et al. ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction (STAT-MI) trial. , 2007, Journal of the American College of Cardiology.
[91] K. Eagle,et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. , 2007, JAMA.
[92] David G Strauss,et al. Paramedic transtelephonic communication to cardiologist of clinical and electrocardiographic assessment for rapid reperfusion of ST-elevation myocardial infarction. , 2007, Journal of electrocardiology.
[93] F. Fernández‐Avilés,et al. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. , 2007, European heart journal.
[94] J. Herlitz,et al. Treatment and outcome in post-resuscitation care after out-of-hospital cardiac arrest when a modern therapeutic approach was introduced. , 2007, Resuscitation.
[95] D. Davis,et al. The Positive Predictive Value of Paramedic Versus Emergency Physician Interpretation of the Prehospital 12-Lead Electrocardiogram , 2007, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.
[97] I. Stiell,et al. Comparison of early mortality of paramedic-diagnosed ST-segment elevation myocardial infarction with immediate transport to a designated primary percutaneous coronary intervention center to that of similar patients transported to the nearest hospital. , 2006, The American journal of cardiology.
[98] David P Miller,et al. Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy , 2006, Circulation.
[99] G. Schuler,et al. ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention. , 2006, The American journal of cardiology.
[100] F. Verheugt,et al. Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: the randomised Holland Infarction Study (HIS) , 2006, Journal of Thrombosis and Thrombolysis.
[101] P. Armstrong. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. , 2006, European heart journal.
[102] J. Ottervanger,et al. Feasibility and benefit of prehospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarction. , 2006, American heart journal.
[103] A. Kirtane,et al. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) r , 2006, American heart journal.
[104] M. Zehender,et al. Primary percutaneous coronary intervention in acute myocardial infarction: Direct transportation to catheterization laboratory by emergency teams reduces door‐to‐balloon time , 2006, Clinical cardiology.
[105] P. Armstrong,et al. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial , 2006, The Lancet.
[106] Robert Swor,et al. Prehospital 12-Lead ECG: Efficacy or Effectiveness? , 2006, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.
[107] G. Wells,et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). , 2005, Journal of the American College of Cardiology.
[108] C. Terkelsen,et al. Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention. , 2005, European heart journal.
[109] Kathryn Brinsfield,et al. Real-time paramedic compared with blinded physician identification of ST-segment elevation myocardial infarction: results of an observational study. , 2005, The American journal of emergency medicine.
[110] E. Antman,et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. , 2005, JAMA.
[111] A. Skene,et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. , 2005, The New England journal of medicine.
[112] Ukholkina Gb,et al. Effect of oxygenotherapy used in combination with reperfusion in patients with acute myocardial infarction , 2005 .
[113] N. Kuchkina,et al. [Effect of oxygenotherapy used in combination with reperfusion in patients with acute myocardial infarction]. , 2005, Kardiologiia.
[114] F. Fernández‐Avilés,et al. Routine invasive strategy within 24 hours of thrombolysis versus ischemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): A randomized controlled trial , 2004 .
[115] K. Huber,et al. Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study. , 2004, European heart journal.
[116] J. Gore,et al. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction. , 2004, Archives of internal medicine.
[117] Richard Nowak,et al. A change in serum myoglobin to detect acute myocardial infarction in patients with normal troponin I levels. , 2004, The American journal of cardiology.
[118] F. Fernández‐Avilés,et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial , 2004, The Lancet.
[119] M. Pfeffer,et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. , 2004, JAMA.
[120] S. Yusuf,et al. Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial , 2004, Circulation.
[121] Paul Dorian,et al. The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group. , 2004, The Canadian journal of cardiology.
[122] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.
[123] V. Hasselblad,et al. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. , 2004, JAMA.
[124] R. Califf,et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. , 2004, JAMA.
[125] H. Brewer. Focus on high-density lipoproteins in reducing cardiovascular risk. , 2004, American heart journal.
[126] Á. Avezum,et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. , 2004, JAMA.
[127] A. Murphy,et al. The potential use of prehospital thrombolysis in a rural community. , 2004, Resuscitation.
[128] J. J. Griffin,et al. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction. , 2004, Journal of the American College of Cardiology.
[129] H. Suryapranata,et al. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial. , 2004, European heart journal.
[130] H. Suryapranata,et al. Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty. , 2004, Journal of the American College of Cardiology.
[131] R. Tamura,et al. Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction. , 2004, American heart journal.
[132] J. Herlitz,et al. Prognostic value of biochemical markers, 12‐lead ECG and patient characteristics amongst patients calling for an ambulance due to a suspected acute coronary syndrome , 2004, Journal of internal medicine.
[133] Elliott M. Antman,et al. Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction: Every Minute of Delay Counts , 2004, Circulation.
[134] R. Giugliano,et al. Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction. , 2004, Journal of the American College of Cardiology.
[135] B. Delaney,et al. Systematic review and modelling of the investigation of acute and chronic chest pain presenting in primary care. , 2004, Health technology assessment.
[136] E. Pérez,et al. Feasibility and Timing of Prehospital Administration of Reteplase in Patients with Acute Myocardial Infarction , 2002, Journal of Thrombosis and Thrombolysis.
[137] F. Spencer,et al. Low Molecular Weight Heparin and Unfractionated Heparin in the Early Pharmacologic Management of Acute Coronary Syndromes: A Meta-analysis of Randomized Clinical Trials , 2001, Journal of Thrombosis and Thrombolysis.
[138] Thomas Weber,et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.
[139] M. Doyle,et al. Improving Door-to-Drug time and ST segment resolution in AMI by moving thrombolysis administration to the Emergency Department. , 2004, Accident and emergency nursing.
[140] C. Henrikson,et al. Chest Pain Relief by Nitroglycerin Does Not Predict Active Coronary Artery Disease , 2003, Annals of Internal Medicine.
[141] R. Giugliano,et al. Selecting the best reperfusion strategy in ST-elevation myocardial infarction: it's all a matter of time. , 2003, Circulation.
[142] P. Touboul,et al. Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial , 2003, Circulation.
[143] Mauricio G. Cohen,et al. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase. , 2003, American heart journal.
[144] S. Goodacre,et al. Clinical predictors of acute coronary syndromes in patients with undifferentiated chest pain. , 2003, QJM : monthly journal of the Association of Physicians.
[145] D. Moser,et al. Women’s Early Warning Symptoms of Acute Myocardial Infarction , 2003, Circulation.
[146] Karl Swedberg,et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.
[147] T. Mcconnell,et al. Clinical Predictors of 30-day Cardiac Events in Patients with Acute Coronary Syndrome at a Community Hospital , 2003, Southern medical journal.
[148] E. Topol,et al. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. , 2003, JAMA.
[149] H. White,et al. The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial. , 2003, Journal of the American College of Cardiology.
[150] M. Dalby,et al. Transfer for Primary Angioplasty Versus Immediate Thrombolysis in Acute Myocardial Infarction: A Meta-Analysis , 2003, Circulation.
[151] S. Yusuf,et al. Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes: Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study , 2003, Circulation.
[152] P. Libby,et al. High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study , 2003, Circulation.
[153] H. Suryapranata,et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. , 2003, Journal of the American College of Cardiology.
[154] M. Simoons,et al. Prehospital thrombolysis with reteplase: the Nijmegen/Rotterdam study. , 2003, American heart journal.
[155] W. Weaver,et al. The prognostic significance of serial myoglobin, troponin I, and creatine kinase-MB measurements in patients evaluated in the emergency department for acute coronary syndrome. , 2003, Annals of emergency medicine.
[156] J. Fisher,et al. Predictors of delay in presentation to the ED in patients with suspected acute coronary syndromes. , 2003, The American journal of emergency medicine.
[157] M. Aschermann,et al. Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study). , 2003, The Canadian journal of cardiology.
[158] S. Heath,et al. Nurse initiated thrombolysis in the accident and emergency department: safe, accurate, and faster than fast track , 2003, Emergency medicine journal : EMJ.
[159] Klaus Rasmussen,et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. , 2003, The New England journal of medicine.
[160] C. Hofer,et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. , 2003, Journal of the American College of Cardiology.
[161] P. Armstrong,et al. Efficacy and Safety of Tenecteplase in Combination With the Low-Molecular-Weight Heparin Enoxaparin or Unfractionated Heparin in the Prehospital Setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS Randomized Trial in Acute Myocardial Infarction , 2003, Circulation.
[162] A. Favero,et al. Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics , 2003, British medical journal.
[163] S. Shaw,et al. Safety and feasibility of prehospital thrombolysis carried out by paramedics , 2003, BMJ : British Medical Journal.
[164] M. Kayıkçıoğlu,et al. The effect of statin therapy on ventricular late potentials in acute myocardial infarction. , 2003, International journal of cardiology.
[165] J. Herlitz,et al. Safety and delay time in prehospital thrombolysis of acute myocardial infarction in urban and rural areas in Sweden. , 2003, The American journal of emergency medicine.
[166] W. Gibler,et al. Prospective evaluation of emergency department patients with potential coronary syndromes using initial absolute CK-MB vs. CK-MB relative index. , 2003, The Journal of emergency medicine.
[167] J. Rawles. GREAT: 10 year survival of patients with suspected acute myocardial infarction in a randomised comparison of prehospital and hospital thrombolysis , 2003, Heart.
[168] C. Granger,et al. Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study. , 2003, European heart journal.
[169] Deepak L. Bhatt,et al. Relation of Inflammation and Benefit of Statins After Percutaneous Coronary Interventions , 2003, Circulation.
[170] R. Welsh,et al. Meta-analysis of randomized trials comparing enoxaparin versus unfractionated heparin as adjunctive therapy to fibrinolysis in ST-elevation acute myocardial infarction. , 2003, The American journal of cardiology.
[171] J. Herlitz,et al. Elevation of biochemical markers for myocardial damage prior to hospital admission in patients with acute chest pain or other symptoms raising suspicion of acute coronary syndrome , 2003, Journal of internal medicine.
[172] J. Gaspoz,et al. Time savings with prehospital thrombolysis in an urban area , 2003, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.
[173] S. Yusuf,et al. Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes , 2003, Circulation.
[174] E. Topol,et al. Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina: One-Year Survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV—Acute Coronary Syndrome) Trial , 2003, Circulation.
[175] B H Rowe,et al. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes. , 2003, The Cochrane database of systematic reviews.
[176] J. Boura,et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .
[177] M. Aschermann,et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2. , 2003, European heart journal.
[178] I. Menown,et al. Impact of pre-hospital care in patients with acute myocardial infarction compared with those first managed in-hospital. , 2003, European heart journal.
[179] G. Rennert,et al. Evaluation of chest pain in the ED: factors affecting triage decisions. , 2003, The American journal of emergency medicine.
[180] E. Ambrosioni,et al. Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study. , 2003, American heart journal.
[181] S. Agewall. Evaluation of point-of-care test systems using the new definition of myocardial infarction. , 2003, Clinical biochemistry.
[182] E. Falk,et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. , 2003, European heart journal.
[183] A. Kratz,et al. Positive predictive value of a point-of-care testing strategy on first-draw specimens for the emergency department-based detection of acute coronary syndromes. , 2009, Archives of pathology & laboratory medicine.
[184] E. Fody,et al. The Erlanger chest pain evaluation protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes. , 2002, Annals of emergency medicine.
[185] G. Specchia,et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2002, European heart journal.
[186] Eric J Topol,et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.
[187] R. Califf,et al. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. , 2002, JAMA.
[188] David A. Edmondson,et al. Prehospital 12-lead ECG diagnostic programs. , 2002, Emergency medicine clinics of North America.
[189] Eugene Crystal,et al. Outcome of Myocardial Infarction in Patients Treated with Aspirin Is Enhanced by Pre-Hospital Administration , 2002, Cardiology.
[190] J. Herlitz,et al. Predicting a life-threatening disease and death among ambulance-transported patients with chest pain or other symptoms raising suspicion of an acute coronary syndrome. , 2002, The American journal of emergency medicine.
[191] R. Collins,et al. Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review , 2002, The Lancet.
[192] Carl J Pepine,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.
[193] M. Ezekowitz,et al. Effects of Atorvastatin on Stroke in Patients With Unstable Angina or Non-Q-Wave Myocardial Infarction: A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Substudy , 2002, Circulation.
[194] S. Yusuf,et al. Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups , 2002, Circulation.
[195] V. Hasselblad,et al. Seeking the optimal aspirin dose in acute coronary syndromes. , 2002, The American journal of cardiology.
[196] P. Touboul,et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study , 2002, The Lancet.
[197] C. Wilson,et al. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction. , 2002, European heart journal.
[198] R. Gibbons,et al. Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. , 2002, European heart journal.
[199] A. Laggner,et al. Ramipril Prior to Thrombolysis Attenuates the Early Increase of PAI-1 in Patients with Acute Myocardial Infarction , 2002, Thrombosis and Haemostasis.
[200] M. Kayıkçıoğlu,et al. Early use of pravastatin in patients with acute myocardial infarction undergoing coronary angioplasty. , 2002, Acta cardiologica.
[201] E. Antman,et al. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial. , 2002, Journal of the American College of Cardiology.
[202] H. DeVon,et al. Symptoms of acute coronary syndromes: are there gender differences? A review of the literature. , 2002, Heart & lung : the journal of critical care.
[203] A. Lincoff,et al. GUSTO V: combination drug treatment of acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries. , 2002, Cleveland Clinic journal of medicine.
[204] H. Suryapranata,et al. Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction. , 2002, Journal of the American College of Cardiology.
[205] William W O'Neill,et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. , 2002, Journal of the American College of Cardiology.
[207] H. White,et al. Withdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes , 2002, Circulation.
[208] Steve Goodacre,et al. How useful are clinical features in the diagnosis of acute, undifferentiated chest pain? , 2002, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[209] D. Freimark,et al. Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis. , 2002, The American journal of cardiology.
[210] E. Topol,et al. Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial. , 2002, Journal of the American College of Cardiology.
[211] E. Antman,et al. Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE. , 2002, European heart journal.
[212] R. Califf,et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials , 2002, The Lancet.
[213] T. Coats,et al. Recognition of ST elevation by paramedics , 2002, Emergency medicine journal : EMJ.
[214] J. Dwight,et al. Is the radiation of chest pain a useful indicator of myocardial infarction? A prospective study of 541 patients. , 2002, Accident and emergency nursing.
[215] T. Caragher,et al. Evaluation of quantitative cardiac biomarker point-of-care testing in the emergency department. , 2002, The Journal of emergency medicine.
[216] H. White,et al. Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin. , 2002, American heart journal.
[217] R. Schiele,et al. Clinical practice of primary angioplasty for the treatment of acute myocardial infarction in Germany: results from the MITRA and MIR registries , 2002, Zeitschrift für Kardiologie.
[218] A. Remppis,et al. Effects of intracoronary low-dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction. , 2001, The American journal of cardiology.
[219] Deepak L. Bhatt,et al. Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes , 2001, Circulation.
[220] S. Rockson,et al. Feasibility and Reliability of Rapid Diagnosis of Myocardial Infarction , 2001, The American journal of the medical sciences.
[221] E. Braunwald,et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. , 2001, JAMA.
[222] E. Antman,et al. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience). , 2001, The American journal of cardiology.
[223] C. Vassanelli,et al. [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[224] James McCord,et al. Ninety-Minute Exclusion of Acute Myocardial Infarction By Use of Quantitative Point-of-Care Testing of Myoglobin and Troponin I , 2001, Circulation.
[225] R. Fitzgerald,et al. Ninety-minute accelerated critical pathway for chest pain evaluation. , 2001, The American journal of cardiology.
[226] M. Ezekowitz,et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. , 2001, JAMA.
[227] Assent investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction , 2001, The Lancet.
[228] Salim Yusuf,et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study , 2001, The Lancet.
[229] K. Mackway-Jones,et al. Is it possible to exclude a diagnosis of myocardial damage within six hours of admission to an emergency department? Diagnostic cohort study , 2001, BMJ : British Medical Journal.
[230] H. Katus,et al. Admission Troponin T Level Predicts Clinical Outcomes, TIMI Flow, and Myocardial Tissue Perfusion After Primary Percutaneous Intervention for Acute ST-Segment Elevation Myocardial Infarction , 2001, Circulation.
[231] A. Go,et al. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. , 2001, Journal of the American College of Cardiology.
[232] E. Topol. Recent advances in anticoagulant therapy for acute coronary syndromes. , 2001, American heart journal.
[233] V. Vaccarino,et al. Symptom Predictors of Acute Coronary Syndromes in Younger and Older Patients , 2001, Nursing research.
[234] R. Schiele,et al. Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis. , 2001, American heart journal.
[235] M. Simoons. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial , 2001, The Lancet.
[236] F. Verheugt,et al. PRAVASTATIN IN ACUTE ISCHAEMIC SYNDROMES: RESULTS OF A RANDOMISED PLACEBO‐CONTROLLED TRIAL , 2001, International journal of clinical practice.
[237] H. Pereira,et al. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial , 2001, The Lancet.
[238] J. Ioannidis,et al. Accuracy and clinical effect of out-of-hospital electrocardiography in the diagnosis of acute cardiac ischemia: a meta-analysis. , 2001, Annals of emergency medicine.
[239] P. Bijur,et al. Six-hour versus 12-hour protocols for AMI: CK-MB in conjunction with myoglobin. , 2001, The American journal of emergency medicine.
[240] J. Ioannidis,et al. Diagnosing acute cardiac ischemia in the emergency department: a systematic review of the accuracy and clinical effect of current technologies. , 2001, Annals of emergency medicine.
[241] S. Nissen,et al. Normal CK, elevated MB predicts complications in acute coronary syndromes. , 2001, The Journal of emergency medicine.
[242] J. Ioannidis,et al. Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: a meta-analysis. , 2001, Annals of emergency medicine.
[243] T. Takano,et al. Cardiac emergency triage and therapeutic decisions using whole blood rapid troponin T test for patients with suspicious acute coronary syndrome. , 2001, Japanese circulation journal.
[244] R. Fitzgerald,et al. Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. , 2001, The American journal of cardiology.
[245] G. Nichol,et al. Stenting versus thrombolysis in acute myocardial infarction trial (STAT). , 2001, Journal of the American College of Cardiology.
[246] S. Malhotra,et al. A randomized trial to compare the efficacy, safety, cost and platelet aggregation effects of enoxaparin and unfractionated heparin (the ESCAPEU trial). , 2001, International journal of clinical pharmacology and therapeutics.
[247] D. Eterović,et al. Correlation between symptomatology and site of acute myocardial infarction. , 2001, International journal of cardiology.
[248] H. White,et al. One-year survival following early revascularization for cardiogenic shock. , 2001, JAMA.
[249] J. Chambers,et al. Biochemical markers in the management of suspected acute myocardial infarction in the emergency department , 2001, Emergency medicine journal : EMJ.
[250] P. R. R. Ecurrent,et al. EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .
[251] J. Rumsfeld,et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. , 2000, JAMA.
[252] L. Wallentin,et al. Comparison between strategies using creatine kinase-MB(mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiogram. , 2000, The American journal of cardiology.
[253] H. Schultheiss,et al. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). , 2000, The American journal of cardiology.
[254] E. Antman,et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. , 2000, Journal of the American College of Cardiology.
[255] J. Ornato,et al. Ability of troponin I to predict cardiac events in patients admitted from the emergency department. , 2000, Journal of the American College of Cardiology.
[256] G. Bernardi,et al. [Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[257] G. L. Higgins,et al. A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT). , 2000, Journal of the American College of Cardiology.
[258] R. Califf,et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial. , 2000, Journal of the American College of Cardiology.
[259] S. Kaul,et al. Elevated Troponin I Level on Admission Is Associated With Adverse Outcome of Primary Angioplasty in Acute Myocardial Infarction , 2000, Circulation.
[260] D. Chan,et al. CK-MB isoforms for early risk stratification of emergency department patients. , 2000, Clinica chimica acta; international journal of clinical chemistry.
[261] F. Verheugt,et al. Successful out-of-hospital cardiopulmonary resuscitation: what is the optimal in-hospital treatment strategy? , 2000, Resuscitation.
[262] J. Vítovec,et al. First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction. , 2000, International journal of cardiology.
[263] E. Antman,et al. Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram. , 2000, American heart journal.
[264] L. Wallentin,et al. The combination of a continuous 12-lead ECG and troponin T; a valuable tool for risk stratification during the first 6 hours in patients with chest pain and a non-diagnostic ECG. , 2000, European heart journal.
[265] M. Simoons,et al. Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction; a phase II dose escalation, randomized, double-blind study. , 2000, European heart journal.
[266] J. Ottervanger,et al. Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction. , 2000, European heart journal.
[267] M. Schwaiger,et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. , 2000, The New England journal of medicine.
[268] M. Ebell,et al. A systematic review of troponin T and I values as a prognostic tool for patients with chest pain. , 2000, The Journal of family practice.
[269] A. Semb,et al. Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study. , 2000, Clinical therapeutics.
[270] D. Mountain,et al. Changing the site of delivery of thrombolytic treatment for acute myocardial infarction from the coronary care unit to the emergency department greatly reduces door to needle time , 2000, Heart.
[271] S. Osganian,et al. Age and sex differences in presentation of symptoms among patients with acute coronary disease: the REACT Trial. Rapid Early Action for Coronary Treatment. , 2000, Coronary artery disease.
[272] J P Ornato,et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. , 2000, JAMA.
[273] E W Steyerberg,et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. , 2000, Circulation.
[274] S. Yusuf,et al. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis , 2000, The Lancet.
[275] R. Collins,et al. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab , 2000, Journal of the American College of Cardiology.
[276] W. Rogers,et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. , 2000, The New England journal of medicine.
[277] L. Morrison,et al. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. , 2000, JAMA.
[278] H. Suryapranata,et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. , 2000, European heart journal.
[279] H. Helenius,et al. Prediction of short-term outcome in patients with suspected myocardial infarction. , 2000, Annals of emergency medicine.
[280] G. Wagner,et al. Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac troponin-T, myoglobin, and creatine kinase MB(mass) , 2000, European heart journal.
[281] C. Maynard,et al. Prehospital ECG transmission speeds reperfusion for patients with acute myocardial infarction. , 2000, North Carolina medical journal.
[282] E. Antman,et al. Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: Proposed revisions , 2000 .
[283] S. Nissen,et al. Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes. , 2000, The American journal of cardiology.
[284] J. Lijmer,et al. Diagnostic accuracy of myoglobin concentration for the early diagnosis of acute myocardial infarction. , 2000, Annals of emergency medicine.
[285] I. Menown,et al. Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. , 2000, European heart journal.
[286] F. Fesmire,et al. Delta CK-MB outperforms delta troponin I at 2 hours during the ED rule out of acute myocardial infarction. , 2000, The American journal of emergency medicine.
[287] M. Grzybowski,et al. A prediction model for prehospital triage of patients with suspected cardiac ischemia. , 2000, Journal of electrocardiology.
[288] L. Wallentin,et al. Early diagnosis and exclusion of acute myocardial infarction by two hours' vector-ECG and determination of either myoglobin or CK-mb. BIOMACS-study. BIOchemical Markers in Acute Coronary Syndromes. , 2000, Scandinavian cardiovascular journal : SCJ.
[289] E. Antman,et al. Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: proposed revisions. International Cardiology Forum. , 2000, American heart journal.
[290] Arthur N. L. Chiu,et al. Troponin-I, myoglobin, and mass concentration of creatine kinase-MB in acute myocardial infarction. , 1999, QJM : monthly journal of the Association of Physicians.
[291] R. Califf,et al. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. , 1999, The American journal of cardiology.
[292] S. Greenhouse,et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial , 1999 .
[293] M. Smyth,et al. A comparative bioavailability study of different aspirin formulations using on-line multidimensional chromatography. , 1999, Journal of pharmaceutical and biomedical analysis.
[294] G. Hillis,et al. Utility of cardiac troponin I, creatine kinase-MBmass, myosin light chain 1, and myoglobin in the early in-hospital triage of “high risk” patients with chest pain , 1999, Heart.
[295] E. Antman,et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.
[296] E. Antman,et al. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. , 1999, Circulation.
[297] W. Dassen,et al. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study , 1999, Heart.
[298] Tang Ming,et al. Initiation of thrombolytic therapy for patients with acute myocardial infarction by emergency physicians: The Hong Kong experience , 1999 .
[299] M. Levitt,et al. Serial use of bedside CKMB/myoglobin device to detect acute myocardial infarction in emergency department chest pain patients. , 1999, The Journal of emergency medicine.
[300] F. Morris,et al. Thrombolysis in acute myocardial infarction: the safety and efficiency of treatment in the accident and emergency department. , 1999, Journal of accident & emergency medicine.
[301] H. White,et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.
[302] M. Feldman,et al. Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution. , 1999, The American journal of cardiology.
[303] R. Califf,et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. , 1999, Circulation.
[304] T. Meinertz,et al. Prehospital testing for troponin T in patients with suspected acute myocardial infarction. , 1999, American heart journal.
[305] J. Tardif,et al. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. , 1999, Circulation.
[306] E. Kaplinsky,et al. Assessment of a creatine kinase-MB/myoglobin kit in the prehospital setting in patients presenting with acute nontraumatic chest pain: the "Shahal" experience. , 1999, Critical care medicine.
[307] E. Antman,et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. , 1999, Circulation.
[308] C. Granger,et al. Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction. , 1999, American heart journal.
[309] J. Zimmerman,et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. , 1999, Circulation.
[310] G. Hobbs,et al. Prehospital identification of acute coronary ischemia using a troponin T rapid assay. , 1999, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.
[311] J. O’Keefe,et al. Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. , 1999, Journal of the American College of Cardiology.
[312] J. López-Sendón,et al. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. , 1999, Journal of the American College of Cardiology.
[313] E. Cook,et al. Value of additional two-hour myoglobin for the diagnosis of myocardial infarction in the emergency department. , 1999, The American journal of cardiology.
[314] F. Apple,et al. Implementation of serum cardiac troponin I as marker for detection of acute myocardial infarction. , 1999, American heart journal.
[315] R. Califf,et al. Effect of age on outcome with primary angioplasty versus thrombolysis. , 1999, Journal of the American College of Cardiology.
[316] S. Greenhouse,et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial. , 1999, Journal of the American College of Cardiology.
[317] K. Pyörälä,et al. Myoglobin, creatine kinase MB, troponin T, and troponin I — rapid bedside assays in patients with acute chest pain , 1999, International journal of clinical & laboratory research.
[318] K. Thygesen,et al. Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease (A thrombin inhibition in myocardial ischemia [TRIM] substudy). The TRIM Study Group. , 1998, Circulation.
[319] A. Vado,et al. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. , 1998, Journal of the American College of Cardiology.
[320] Gordon H. Guyatt,et al. Is This Patient Having a Myocardial Infarction , 1998 .
[321] M. Melville,et al. The Potential Impact of Prehospital Electrocardiography and Telemetry on Time to Thrombolysis in a United Kingdom Center , 1998 .
[322] R. B. Myers. Prehospital management of acute myocardial infarction: Electrocardiogram acquisition and interpretation, and thrombolysis by prehospital care providers. , 1998, The Canadian journal of cardiology.
[323] D. Chan,et al. The prognostic significance of troponin I and troponin T. , 1998, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[324] F. Fesmire,et al. Serial creatinine kinase (CK) MB testing during the emergency department evaluation of chest pain: utility of a 2-hour deltaCK-MB of +1.6ng/ml. , 1998, American heart journal.
[325] M. P. Larsen,et al. Gender differences in reported symptoms for acute myocardial infarction: impact on prehospital delay time interval. , 1998, The American journal of emergency medicine.
[326] E. Cook,et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. , 1998, Journal of the American College of Cardiology.
[327] D. Waters,et al. Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. , 1998, The American journal of cardiology.
[328] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[329] R. Collins,et al. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. , 1998, Circulation.
[330] H. White,et al. Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction. , 1998, Journal of the American College of Cardiology.
[331] D Sapoznikov,et al. Prevention of congestive heart failure by early, prehospital thrombolysis in acute myocardial infarction: a long-term follow-up study. , 1998, International journal of cardiology.
[332] A. Maresta,et al. The magnitude of the benefit from preCCU thrombolysis in acute myocardial infarction: a long term follow up. , 1998, International journal of cardiology.
[333] R D Sidman,et al. Measurement of cardiac troponin T is an effective method for predicting complications among emergency department patients with chest pain. , 1998, Annals of emergency medicine.
[334] E. Martin,et al. Bedside troponin T testing is not useful for early out‐of‐hospital diagnosis of myocardial infarction , 1998, Acta anaesthesiologica Scandinavica.
[335] B. Magnani,et al. Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party. , 1998, American heart journal.
[336] S. Banerjee,et al. Fast-tracking of Myocardial Infarction by Paramedics , 1998, Journal of the Royal College of Physicians of London.
[337] R. Gibbons,et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. , 1998, JAMA.
[338] Wilson At,et al. Hypoxaemia and supplemental oxygen therapy in the first 24 hours after myocardial infarction: the role of pulse oximetry. , 1997 .
[339] J. Kellett. Early diagnosis of acute myocardial infarction by either electrocardiogram or a logistic regression model: portability of a predictive instrument of acute cardiac ischemia to a small rural coronary care unit. , 1997, The Canadian journal of cardiology.
[340] M. Millar-Craig,et al. Reduction in treatment delay by paramedic ECG diagnosis of myocardial infarction with direct CCU admission , 1997, Heart.
[341] R. Califf,et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. , 1997 .
[342] J. Chambers,et al. Comparative study of chest pain characteristics in patients with normal and abnormal coronary angiograms. , 1997, Heart.
[343] R. Califf,et al. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. , 1997, Circulation.
[344] S. Solomon,et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. , 1997, Circulation.
[345] H. Suryapranata,et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. , 1997, Journal of the American College of Cardiology.
[346] W. Weaver,et al. The prehospital electrocardiogram in acute myocardial infarction: is its full potential being realized? National Registry of Myocardial Infarction 2 Investigators. , 1997, Journal of the American College of Cardiology.
[347] D. Pahlajani,et al. Comparison of clinical outcome of fixed-dose subcutaneous low molecular weight heparin (tinzaparin) with conventional heparin in unstable angina: a pilot study. , 1997, Indian heart journal.
[348] R. Califf,et al. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. , 1997, Circulation.
[349] K. Channer,et al. Hypoxaemia and Supplemental Oxygen Therapy in the First 24 Hours after Myocardial Infarction: The Role of Pulse Oximetry , 1997, Journal of the Royal College of Physicians of London.
[350] T. Hedner,et al. Localization of pain in suspected acute myocardial infarction in relation to final diagnosis, age and sex, and site and type of infarction. , 1996, Heart & lung : the journal of critical care.
[351] I. Jacobs,et al. The use of thrombolytic therapy in patients presenting to a peripheral metropolitan emergency department with acute myocardial infarction. , 1996, Australian and New Zealand journal of medicine.
[352] P. Kudenchuk,et al. Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (the Myocardial Infarction Triage and Intervention Registry) , 1996, The American journal of cardiology.
[353] J. Deckers,et al. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients. , 1995, European heart journal.
[354] M. Flather,et al. ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. , 1995, Circulation.
[355] R. M. Rubison,et al. Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the National Registry of Myocardial Infarction). Participants in the National Registry of Myocardial Infarction. , 1995, The American journal of cardiology.
[356] H. Darius,et al. Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses. , 1995, American heart journal.
[357] S. Coccolini,et al. Prehospital thrombolysis in rural emergency room and subsequent transport to a coronary care unit: Ravenna Myocardial Infarction (RaMI) trial. , 1995, International journal of cardiology.
[358] E. Gurfinkel,et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. , 1995, Journal of the American College of Cardiology.
[359] M. Gotsman,et al. Early intravenous thrombolysis in acute myocardial infarction: the Jerusalem experience. , 1995, International journal of cardiology.
[360] R. Collins,et al. Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1) , 1995, The Lancet.
[361] Raymond C. Schneider,et al. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.
[362] Edward Guadagnoli,et al. Failure of Information as an Intervention to Modify Clinical Management: A Time-Series Trial in Patients with Acute Chest Pain , 1995, Annals of Internal Medicine.
[363] S. Yusuf,et al. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. , 1995, Circulation.
[364] B. Magnani,et al. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. , 1995, The New England journal of medicine.
[365] E. Topol,et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. , 1994, Circulation.
[366] D. Foster,et al. Prehospital recognition of AMI using independent nurse/paramedic 12-lead ECG evaluation: impact on in-hospital times to thrombolysis in a rural community hospital. , 1994, The American journal of emergency medicine.
[367] Pre-hospital treatment of patients with suspected acute myocardial using a beta-blocking agent: a double-blind feasibility study. EMIP-BB Pilot Study Group. , 1994, Clinical trials and meta-analysis.
[368] S. Cannizzaro,et al. Does captopril treatment before thrombolysis in acute myocardial infarction attenuate reperfusion damage? Short-term and long-term effects. , 1994, International journal of cardiology.
[370] J. Rawles. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). , 1994, Journal of the American College of Cardiology.
[371] T. Taddei,et al. Early out-of-hospital lidocaine administration decreases the incidence of primary ventricular fibrillation in acute myocardial infarction. , 1993, The Journal of emergency medicine.
[372] C. Furberg,et al. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. , 1993, JAMA.
[373] P. Kudenchuk,et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. , 1993, JAMA.
[374] Early angiography and angioplasty following thrombolytic therapy of acute myocardial infarction. Metaanalysis of the randomized control trials. , 1993, The Online journal of current clinical trials.
[375] D. Tsikas,et al. Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in man. , 1993, Clinical science.
[376] J. Rawles. Delays to Thrombolysis in the Treatment of Myocardial Infarction , 1993, Journal of the Royal College of Physicians of London.
[377] J O'Keefe,et al. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .
[378] I. Ford,et al. Early treatment with captopril after acute myocardial infarction. , 1993, British heart journal.
[379] C. Y. Lu. [Treatment of acute myocardial infarction with oral captopril. A randomized, double blind and placebo controlled pilot study]. , 1993, Zhonghua xin xue guan bing za zhi.
[380] K. Rasmussen,et al. Lidocaine to prevent ventricular fibrillation in the prehospital phase of suspected acute myocardial infarction: the North-Norwegian Lidocaine Intervention Trial. , 1992, American heart journal.
[381] W. O’Neill,et al. A Prospective, Placebo‐Controlled, Randomized Trial of Intravenous Streptokinase and Angioplasty Versus Lone Angioplasty Therapy of Acute Myocardial Infarction , 1992, Circulation.
[382] K. Swedberg,et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) , 1992, The New England journal of medicine.
[383] S. Kristensen,et al. Intravenous Acetylsalicylic Acid – Dose-Related Effects on Platelet Function and Fibrinolysis in Healthy Males , 1992, Thrombosis and Haemostasis.
[384] M. Simoons,et al. Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction. , 1992, European heart journal.
[385] T. Aufderheide,et al. Feasibility of prehospital r-TPA therapy in chest pain patients. , 1992, Annals of emergency medicine.
[386] W. Gibler,et al. Relative importance of emergency medical system transport and the prehospital electrocardiogram on reducing hospital time delay to therapy for acute myocardial infarction: a preliminary report from the Cincinnati Heart Project. , 1992, American heart journal.
[387] S. Fletcher,et al. Intravenous magnesium in suspected acute myocardial infarction. , 1992, BMJ.
[388] T. Aufderheide,et al. A prospective evaluation of prehospital 12-lead ECG application in chest pain patients. , 1992, Journal of electrocardiology.
[389] R Peto,et al. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. , 1991, BMJ.
[390] S. Hohnloser,et al. Usefulness of esmolol in unstable angina pectoris , 1991 .
[391] R. Califf,et al. Evaluation of Combination Thrombolytic Therapy and Timing of Cardiac Catheterization in Acute Myocardial Infarction: Results of Thrombolysis and Angioplasty in Myocardial Infarction–Phase5 Randomized Trial , 1991, Circulation.
[392] K. Arnesen,et al. Rapid and correct diagnosis of myocardial infarction: standardized case history and clinical examination provide important information for correct referral to monitored beds , 1991, Journal of internal medicine.
[393] E. Topol,et al. A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction. , 1991, Journal of the American College of Cardiology.
[394] W. Rogers,et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. , 1991, Circulation.
[395] S. Gellis,et al. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group. , 1991 .
[396] K. Swedberg,et al. Prehospital thrombolysis in suspected acute myocardial infarction: results from the TEAHAT Study. , 1991, Journal of internal medicine. Supplement.
[397] F. Sheehan,et al. Prehospital thrombolysis in acute myocardial infarction. , 1990, The American journal of cardiology.
[398] J. Anderson,et al. Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. , 1990, The American journal of cardiology.
[399] S. Behar,et al. Beneficial effect of magnesium sulfate in acute myocardial infarction. , 1990, The American journal of cardiology.
[400] H. Hod,et al. Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction. , 1990, The American journal of cardiology.
[401] H. Hod,et al. Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. , 1990, Journal of the American College of Cardiology.
[402] T. Buclin,et al. Right arm involvement and pain extension can help to differentiate coronary diseases from chest pain of other origin: a prospective emergency ward study of 278 consecutive patients admitted for chest pain , 1990, Journal of internal medicine.
[403] P. D. Chapman,et al. Prehospital prophylactic lidocaine does not favorably affect outcome in patients with chest pain. , 1989, Annals of emergency medicine.
[404] T. Aufderheide,et al. The diagnostic impact of prehospital 12-lead electrocardiography. , 1989, Annals of emergency medicine.
[405] R. Kloner,et al. Cardioprotective effects of captopril in myocardial ischaemia, ischaemia/reperfusion and infarction. , 1990, European heart journal.
[406] P. Kułakowski,et al. Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate. , 1989, American heart journal.
[407] N. Laird,et al. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. , 1989, Archives of internal medicine.
[408] A. Castaigne,et al. Prehospital use of APSAC: results of a placebo-controlled study. , 1989, The American journal of cardiology.
[409] C. Drummond. One-year death rate in 270 patients with suspected acute myocardial infarction initially treated with intravenous magnesium or placebo , 1989 .
[410] T. Feldman,et al. Evaluation of patients for the need of thrombolytic therapy in the prehospital setting. , 1989, Annals of emergency medicine.
[411] J P Roos,et al. Emergency room infusion of intravenous streptokinase in acute myocardial infarction: feasibility, safety, and hemodynamic consequences. , 1989, American heart journal.
[412] R. Collins,et al. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. , 1988, JAMA.
[413] A. Rademaker,et al. Prophylactic versus selective lidocaine for early ventricular arrhythmias of myocardial infarction. , 1988, Journal of the American College of Cardiology.
[414] R. Califf,et al. Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction. , 1988, Circulation.
[415] E F Cook,et al. A computer protocol to predict myocardial infarction in emergency department patients with chest pain. , 1988, The New England journal of medicine.
[416] H. Lambertz,et al. THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY , 1988, The Lancet.
[417] J. Schaider. Nausea and vomiting during acute myocardial infarction and its relation to infarct size and location , 1988 .
[418] Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group. , 1988, JAMA.
[419] J R Mateer,et al. Limitations of prehospital predictors of acute myocardial infarction and unstable angina. , 1987, Annals of emergency medicine.
[420] T. Feldman,et al. Cellular telephone transmission of 12-lead electrocardiograms from ambulance to hospital. , 1987, The American journal of cardiology.
[421] K. Lee,et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. , 1987, The New England journal of medicine.
[422] G W Rouan,et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. , 1987, The American journal of cardiology.
[423] P. Lechleitner,et al. [Preventive use of lidocaine in the prehospital phase of acute myocardial infarct]. , 1987, Wiener medizinische Wochenschrift.
[424] E. Topol,et al. A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. , 1987, Circulation.
[425] A. Rademaker,et al. Character of adverse effects of prophylactic lidocaine in the coronary care unit , 1986, Clinical pharmacology and therapeutics.
[426] D. Sackett,et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. , 1985, The New England journal of medicine.
[427] J. Mccomb,et al. Prophylactic lidocaine in the early phase of suspected myocardial infarction. , 1985, American heart journal.
[428] K. Kuck,et al. [Ineffective use of lidocaine in preventing reperfusion arrhythmias in patients with acute myocardial infarct]. , 1985, Zeitschrift fur Kardiologie.
[429] E F Cook,et al. Acute chest pain in the emergency room. Identification and examination of low-risk patients. , 1985, Archives of internal medicine.
[430] K. Swedberg,et al. Göteborg Metoprolol Trial: effects on arrhythmias. , 1984, The American journal of cardiology.
[431] M. LeWinter,et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.
[432] P. F. Barnaby,et al. Routine prophylactic lidocaine in acute myocardial infarction. , 1983, Heart & lung : the journal of critical care.
[433] K. Swedberg,et al. The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. , 1983, Circulation.
[434] C. Kumana,et al. A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction. , 1982, British journal of clinical pharmacology.
[435] Jeffrey A. Stem,et al. A computer-derived protocol to aid in the diagnosis of emergency room patients with acute chest pain. , 1982, The New England journal of medicine.
[436] C. Hennekens,et al. LIGNOCAINE PROPHYLAXIS IN ACUTE MYOCARDIAL INFARCTION: AN EVALUATION OF RANDOMISED TRIALS , 1981, The Lancet.
[437] B. Pentecost,et al. Reappraisal of lignocaine therapy in management of myocardial infarction. , 1981, British heart journal.
[438] P. C. Barnes,et al. INTRAVENOUS AND ORAL DISOPYRAMIDE AFTER MYOCARDIAL INFARCTION , 1980, The Lancet.
[439] D. Durrer,et al. Efficacy of lidocaine in preventing primary ventricular fibrillation within 1 hour after a 300 mg intramuscular injection. A double-blind, randomized study of 300 hospitalized patients with acute myocardial infarction. , 1978, The American journal of cardiology.
[440] J. Rawles,et al. Controlled trial of oxygen in uncomplicated myocardial infarction. , 1976, British medical journal.
[441] J. Singh,et al. A controlled trial of intramuscular lidocaine in the prevention of premature ventricular contractions associated with acute myocardial infarction. , 1976, American heart journal.
[442] G. Jennings,et al. ORAL DISOPYRAMIDE IN PROPHYLAXIS OF ARRHYTHMIAS FOLLOWING MYOCARDIAL INFARCTION , 1976, The Lancet.
[443] P. Rossi,et al. [Intramuscular injection of lidocaine in prevention of complications and mortality in acute myocardial infarction: double blind study on 246 cases (author's transl)]. , 1976, Giornale italiano di cardiologia.
[444] E. Braunwald,et al. Reduction of Infarct Size by Oxygen Inhalation Following Acute Coronary Occlusion , 1975, Circulation.
[445] H. Wellens,et al. Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients. , 1974, The New England journal of medicine.
[446] J. Sloman,et al. Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. A double-blind study. , 1974, The New England journal of medicine.
[447] K. O'brien,et al. Prophylactic lignocaine in hospitalized patients with acute myocardial infarction. , 1973, The Medical journal of Australia.
[448] M. Bennett,et al. Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias. , 1972, Lancet.
[449] S. Anderson,et al. Lignocaine given prophylactically to patients with acute myocardial infarction. , 1971, Lancet.
[450] L. Mogensen. Ventricular tachyarrhythmias and lignocaine prophylaxis in acute myocardial infarction. A clinical and therapeutic study. , 1970, Acta medica Scandinavica. Supplementum.